- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Schizophrenia Relapse
Total 6190 results
-
Otsuka Pharmaceutical Development & Commercialization...H. Lundbeck A/SCompleted
-
Sumitomo Pharma America, Inc.TerminatedSchizophreniaUnited States, Serbia, Ukraine, Croatia, Colombia, Russian Federation, Bulgaria, Latvia
-
Sumitomo Pharma America, Inc.CompletedSchizophreniaUnited States, Romania, Russian Federation, Ukraine
-
Neurocrine BiosciencesTerminated
-
Tisento TherapeuticsCompletedSchizophreniaUnited States
-
University of California, DavisTerminatedSchizophreniaUnited States
-
University Hospital, MontpellierAssistance Publique - Hôpitaux de Paris; Assistance Publique Hopitaux De Marseille and other collaboratorsCompleted
-
University Hospital, Strasbourg, FranceTerminated
-
Jazz PharmaceuticalsTerminatedSchizophreniaUnited States, Spain, Poland, Serbia
-
Beth Israel Deaconess Medical CenterDartmouth-Hitchcock Medical CenterActive, not recruiting
-
Janssen Research & Development, LLCCompletedSchizophreniaHong Kong, Poland, Argentina, Russian Federation, Ukraine, Italy
-
Whanin Pharmaceutical CompanyCompletedSchizophreniaKorea, Republic of
-
VA Connecticut Healthcare SystemActive, not recruiting
-
Central South UniversityCompleted
-
Asfendiyarov Kazakh National Medical UniversityCompleted
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedSchizophreniaUnited States, Bulgaria
-
Central South UniversityShanghai Mental Health CenterActive, not recruiting
-
Denovo Biopharma LLCCompletedSchizophreniaUnited States, Mexico, Germany, Russian Federation
-
University of California, San DiegoCompletedSchizophreniaUnited States
-
National Institute of Mental Health and Neuro Sciences...CompletedSchizophrenia
-
Angelini FarmacéuticaTerminated
-
Denovo Biopharma LLCCompleted
-
Denovo Biopharma LLCCompletedSchizophreniaItaly, United States, Spain, Israel
-
Shanghai Mental Health CenterShanghai Pudong New Area Mental Health Center; The Affiliated Brain Hospital...Completed
-
Click Therapeutics, Inc.Boehringer IngelheimCompletedSchizophreniaUnited States
-
Heinrich-Heine University, DuesseldorfUniversity of Cologne; University Hospital, Bonn; University Hospital Tuebingen; University Hospital of Cologne and other collaboratorsCompleted
-
Boehringer IngelheimTerminatedSchizophreniaUnited States, Korea, Republic of, Canada, Japan, Spain, Taiwan, France
-
Sumitomo Pharma Co., Ltd.Completed
-
Sumitomo Pharma Co., Ltd.CompletedSchizophreniaJapan, Korea, Republic of, Taiwan
-
Sumitomo Pharma Co., Ltd.CompletedSchizophreniaJapan, Korea, Republic of, Malaysia, Taiwan
-
University of Maryland, BaltimoreWithdrawnSchizophreniaUnited States
-
Hatay Training and Research HospitalCompleted
-
Organon and CoCompleted
-
SunovionCompletedSchizophreniaUnited States, Ukraine, Russian Federation, Hungary, Romania
-
Organon and CoCompleted
-
BiogenCompletedSchizophreniaUnited States
-
Alkermes, Inc.Completed
-
Shanghai Mental Health CenterChinese Academy of SciencesCompleted
-
University Hospital, Strasbourg, FranceTerminated
-
University of Maryland, BaltimoreTerminated
-
Shanghai Mental Health CenterChinese Academy of SciencesTerminated
-
Brian MillerCompleted
-
Alkermes, Inc.CompletedSchizophreniaUnited States, Puerto Rico
-
Cairo UniversityUniversity of PittsburghCompleted
-
Fundació Institut de Recerca de l'Hospital de la...Sheba Medical Center; iMinds; Semmelweis University; AQuAS, Agència de Qualitat...CompletedSchizophreniaSpain, Hungary, Israel
-
ShireTerminated
-
Otsuka Pharmaceutical Co., Ltd.Completed
-
University of California, San DiegoNational Institute of Mental Health (NIMH)CompletedSchizophreniaUnited States
-
University of Maryland, BaltimoreCompleted